This isn’t InnaMed (YC W17)’s most recent raise. Reg CF · SAFE · Mar 2021 (Closed) is more current.View latest round
via Republic · last checked Oct 8, 2026View campaign
Raised
$1.1M / $1.1M max
100% of ceiling
Investors
2,440
$438.5 avg
Valuation cap
$12M
cap, not an agreed valuation
Financials disclosed in this offering
FY2017–FY2018 · hover for source$0
−$424K
FY2017
$237K
−$475K
FY2018
RevenueNet income
Metric
FY2017 reviewed*
FY2018 audited*
Income statement
Revenue
$0
$237,435
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
-$424,383
-$474,753
Taxes paid
$0
$808
Balance sheet
Cash
$393,754
$844,551
Accounts receivable
$0
$0
Total assets
$438,294
$882,560
Short-term debt
$0
$3,426
Long-term debt
$0
$0
Total liabilities
$0
$3,426
Other
Headcount
—
3
The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Deal terms
Valuation cap$12M
Offering details
Target$50,000
Max$1,070,000
Min investment—
OpenedApr 30, 2019
DeadlineJul 31, 2019
Days active2,720
Links & provenance
Source: Manual
0001773255-19-000001
Last synced Aug 19, 2026
0001773255-19-000001
Last synced Aug 19, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.